Clinical trial

Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension

NCT06405555

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-08-07

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2026-08-07Date precision: day

Registry last updated2026-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Hypotensionunresolved

LV Dysfunctionunresolved

Interventions

Midodrine Oral TabletDRUG · verified · RxNorm: midodrine Oral Tablet

Sponsors & collaborators

Ottawa Heart Institute Research Corporationlead sponsor

Mapped research locations

OttawaOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06405555 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.